Industry insights seminar
12.00-13.00 Webinar Part of a series of seminars featuring selected industry speakers, this time including Dr Bill Haynes of Novo Nordisk. Topic: A multi-omics approach for type 2 diabetes target discovery: identification and characterisation of disease-specific small open reading frame encoded peptides. Sponsored by the University of Oxford BioEscalator. Further information and booking details here. […]